Zealand Pharma A/S’ (CPH:ZEAL) Share Price Boosted 26% But Its Business Prospects Need A Lift Too
Zealand Pharma A/S (CPH:ZEAL) shareholders are no doubt pleased to see that the share price has bounced 26% in the last month, although it is still struggling to make up recently lost ground. Not all shareholders will be feeling jubilant, since the share price is still down a very disappointing 49% in the last twelve months.
Although its price has surged higher, Zealand Pharma may still be sending very bullish signals at the moment with its price-to-sales (or “P/S”) ratio of 3.4x, since almost half of all companies in the Biotechs industry in Denmark have P/S ratios greater than 9.4x and even P/S higher than 40x are not unusual. However, the P/S might be quite low for a reason and it requires further investigation to determine…
